Mohammed H. Qusa - Concepedia

Author

Mohammed H. Qusa

University of Louisiana at Monroe

Also Known As

Mohammed H. Qusa, Mohammed Qusa

Publications

309

Citations

H-Index

Concepts

All Affiliations

University of Louisiana at Monroe Louisiana State University Health Sciences Center Shreveport Auburn University

About

Mohammed H. Qusa is an author at University of Louisiana at Monroe specializing in medicine, breast cancer, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	220
2	Biochemistry	1	1	52
3	Cell Biology	1	1	80
4	Chemistry	1	1	47
5	Immunology	1	1	80

Mohammed H. Qusa

Publications

289

Citations

H-Index

Page 1

	Year	Citations
Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptor Khaldoun S. Abdelwahed, Abu Bakar Siddique, Mohamed M. Mohyeldin, Pharmacological Research Breast OncologyHormonal ReceptorImmunologyPcsk9 SecretionNovel Suppressor	2020	80
Novel liquid-liquid extraction and self-emulsion methods for simplified isolation of extra-virgin olive oil phenolics with emphasis on (-)-oleocanthal and its oral anti-breast cancer activity Abu Bakar Siddique, Hassan Y. Ebrahim, Mohamed M. Mohyeldin, PLoS ONE Self-emulsion MethodsPolyphenolicsOther Evoo PhenolicsBiochemistryMedicine	2019	52
Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer Dana Elkhalifa, Abu Bakar Siddique, Mohammed H. Qusa, European Journal of Medicinal Chemistry Chemoprevention StrategyPolymer-drug ConjugateMedicinePharmacologyBreast Cancer	2019	47
Novel olive oil phenolic (−)-oleocanthal (+)-xylitol-based solid dispersion formulations with potent oral anti-breast cancer activities Mohammed H. Qusa, Abu Bakar Siddique, Sami Nazzal, International Journal of Pharmaceutics Medicinal ChemistryChemoprevention StrategyMedicineSolid Dispersion FormulationsDrug Delivery Systems	2019	41
PCSK9 Axis-Targeting Pseurotin A as a Novel Prostate Cancer Recurrence Suppressor Lead Khaldoun S. Abdelwahed, Abu Bakar Siddique, Mohammed H. Qusa, ACS Pharmacology & Translational Science	2021	22
(-)-Oleocanthal Nutraceuticals for Alzheimer’s Disease Amyloid Pathology: Novel Oral Formulations, Therapeutic, and Molecular Insights in 5xFAD Transgenic Mice Model Afsana Tajmim, Areli K. Cuevas-Ocampo, Abu Bakar Siddique, Nutrients	2021	18
Spontaneous <i>In Vitro</i> and <i>In Vivo</i> Interaction of (−)-Oleocanthal with Glycine in Biological Fluids: Novel Pharmacokinetic Markers Lucy I. Darakjian, Aimilia Rigakou, Andrew Brannen, ACS Pharmacology & Translational Science	2021	15
Comparative Gene Signature of (−)-Oleocanthal Formulation Treatments in Heterogeneous Triple Negative Breast Tumor Models: Oncological Therapeutic Target Insights Mohammed H. Qusa, Khaldoun S. Abdelwahed, Abu Bakar Siddique, Nutrients	2021	14

Page 1